KRYS
Krystal Biotech, Inc.
Stock
$322.28−3.03 (−0.93%)Close Oct 2, 2026
- EBITDA, 2025
- $167M
- YoY, 2025
- +132.9%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $167M | +132.9% |
| 2024 | $72M | — |
| 2023 | −$105M | — |
| 2022 | −$143M | — |
| 2021 | −$66M | — |
| 2020 | −$31M | — |
| 2019 | −$21M | — |
| 2018 | −$12M | — |
| 2017 | −$4.7M | — |
| 2016 | −$1.1M | — |